Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/05/2007EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
12/05/2007EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1861169A2 Method and composition for treating mucosal disorders
12/05/2007EP1861124A2 Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch
12/05/2007EP1861123A2 Synergistic efect of tgf-beta blockade and immunogenic agents on tumors
12/05/2007EP1861111A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs
12/05/2007EP1861109A2 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
12/05/2007EP1861100A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION
12/05/2007EP1861094A2 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors
12/05/2007EP1861091A1 Compounds having lipid lowering properties
12/05/2007EP1861086A2 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane
12/05/2007EP1861077A1 Non invasive method for prevention and treatment of cancer
12/05/2007EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1501522A4 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
12/05/2007EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1368318B1 Calcilytic compounds
12/05/2007EP1263752B1 Lpa receptor agonists and antagonists and methods of use
12/05/2007EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007EP1173252B1 Products for brachytherapy and methods for their production
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007EP0918754B1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
12/05/2007EP0760675B2 Compositions comprising dna damaging agents and p53
12/05/2007CN101084238A Receptor selectivity lymphotoxin derivates
12/05/2007CN101084232A Antiviral oligonucleotides
12/05/2007CN101084218A Imidazotriazines as protein kinase inhibitors
12/05/2007CN101084217A Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
12/05/2007CN101084208A Aromatic amides as inhibitors of c-fms kinase
12/05/2007CN101084204A Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
12/05/2007CN101084013A Cancerous disease modifying antibodies
12/05/2007CN101084012A Methods of treating cancer using il-21 and monoclonal antibody therapy
12/05/2007CN101083991A Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions
12/05/2007CN101083990A Compositions and methods for disruption of brca2-rad51 interaction
12/05/2007CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents
12/05/2007CN101083983A Indole derivatives with antitumor activity
12/05/2007CN101083980A Use of targeted oxidative therapeutic formulation in treatment of cancer
12/05/2007CN101083299A Unsymmetrical Unsymmetrical phthalocyanine material and method for making same
12/05/2007CN101082043A Polyethylene glycol modified L-asparaginyl amine enzyme
12/05/2007CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus
12/05/2007CN101081871A Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof
12/05/2007CN101081870A Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof
12/05/2007CN101081848A Novel polyenes and preparation method and usage thereof
12/05/2007CN101081846A Quinazoline derivative and preparation method and usage thereof
12/05/2007CN101081841A Novel 2'-alpha-hydroxyalkyl taxone compound and preparation method thereof
12/05/2007CN101081315A Medical devices containing rapamycin analogs and method for forming same
12/05/2007CN101081301A Medicinal composition containing pemetrexed
12/05/2007CN101081292A Method for preparation of detumescence powder detoxifcation pellet
12/05/2007CN101081291A Medicine for treating cancer
12/05/2007CN101081290A Chinese medicinal material preparation for relieving pain
12/05/2007CN101081284A Chinese medicinal materials preparation for treating and preventing tumor
12/05/2007CN101081240A Medicinal composition of oxymatrine and polysaccharide
12/05/2007CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease
12/05/2007CN101081228A Medicine composition for treating and preventing stomach and intestine tumor
12/05/2007CN101081225A Medicinal composition for preventing and curing stomach and intestine tumor through epigenetic modification
12/05/2007CN101081219A Composition containing taxane genus compound, the method for preparing the same and the use thereof
12/05/2007CN101081218A Rapid-disintegrated oral film and method for making same
12/05/2007CN101081209A Anticancer composition containing tyrosine kinase restraining agent and taxane
12/05/2007CN101081208A Slow-release injection containing tyrosine kinase restraining agent and platinum compound
12/05/2007CN101081207A Medicine composition containing tyrosine kinase restraining agent
12/05/2007CN101081206A Anti-cancer medicine composition containing tyrosine kinase restraining agent
12/05/2007CN101081049A Green grape health tea
12/05/2007CN100352929C Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element
12/05/2007CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007CN100352922C SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352843C Kdr peptides and vaccines comprising the same
12/05/2007CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof
12/05/2007CN100352838C Interfusion protein of antineoplastic genetic engineering composed of target short peptide of receptor of epidermal growth factor and Lidamycin
12/05/2007CN100352831C Burnet general saponin extract , its preparation method and use
12/05/2007CN100352828C SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application
12/05/2007CN100352810C Fumagillol derivatives and processes for preparing the same
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352512C Recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for making same
12/05/2007CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/05/2007CN100352501C Cripto blocking antibodies and uses thereof
12/05/2007CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor
12/05/2007CN100352493C Method of treating tumors
12/05/2007CN100352446C Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
12/05/2007CN100352441C Combination therapy for the treatment of cancer
12/05/2007CN100352430C Self microemulsifying preparation of curcumin and its preparing process
12/05/2007CN100352426C Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2007US7304144 Antibodies binding to human TSLP Polypeptides
12/04/2007US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice
12/04/2007US7304089 Preparation for improved dietary utilisation
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304066 Pyridyl cyanoguanidine compounds
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304054 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007US7304046 Phosphoramide compounds